PharVision Advisers’s FIGS FIGS Stock Holding History

PharVision Advisers’s Portfolio FIGS Stock Details FIGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,568	Closed	-$347K	–	298
2025 Q4	$347K	Sell	30,568 -18,445	-38%	-$173K	0.18%	199
2025 Q3	$328K	Buy	+49,013	New	+$323K	0.18%	174

Other funds holding FIGS

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PharVision Advisers's FIGS Position: Q1 2026 in Review

PharVision Advisers sold out of FIGS (FIGS) in Q1 2026, closing a stake of 30,568 shares — an estimated $347K sold.

PharVision Advisers first reported a position in FIGS in Q3 2025 and held it in 2 quarters. The position peaked at $347K in Q4 2025. 241 funds tracked by Wall St. Rank hold FIGS as of Q1 2026.

PharVision Advisers reported no remaining FIGS position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 30,568 FIGS shares in Q1 2026, an estimated $347K.
PharVision Advisers first reported a position in FIGS in Q3 2025 and held it in 2 quarters.
PharVision Advisers's FIGS position peaked at $347K in Q4 2025.
241 funds tracked by Wall St. Rank held FIGS as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.